QM3-44662-10357 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-08-09
Dose 1 — Pfizer-BioNTech
2021-08-24
Dose 2 — Pfizer-BioNTech
2021-08-25
Registered in v-safe
2021-08-25
Survey response — days 1–6 daily, dose 2
MedDRA: Heart rate increased, Paraesthesia — Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea

Free text: Increased heart rate. Tingling in left leg

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-08-27
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-08-29
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-08-30
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-08-31
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-09-07
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-09-14
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-09-21
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-09-28
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-10-05
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-11-23
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2022-02-15
Dose 3 — Pfizer-BioNTech
2022-02-22
Survey response — 6 months, dose 2
MedDRA: Supraventricular extrasystoles — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Supraventricular premature complexes

MedDRA releases: 2024-11 · check-in free text available
2022-02-22
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-02-25
Call 1 — Left Voicemail
2022-02-25
Call successful
Participant prefers to complete VAERS report online
2022-05-17
Survey response — 3 months, dose 3
MedDRA: Vomiting — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Vomiting

MedDRA releases: 2024-11 · check-in free text available
2022-05-17
Report sent to call center — 3 months, dose 3
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-05-18
Call 2 — Left Voicemail
2022-05-18
Call 1 — Left Voicemail
2022-08-16
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-08-09	Pfizer-BioNTech	No
2	2021-08-24	Pfizer-BioNTech	No
3	2022-02-15	Pfizer-BioNTech	No

Call center

2 call center cases

1 successful · 1 unsuccessful

See the call center timeline

Free text

Release 9 — days 1–6 daily, dose 2

2021-08-25

Systemic reaction (other): Increased heart rate. Tingling in left leg

Release 11 — 6 months, dose 2

2022-02-22

Symptoms: Supraventricular premature complexes

Release 11 — 3 months, dose 3

2022-05-17

Symptoms: Vomiting

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Supraventricular extrasystoles	·	·	✓
SD	Vomiting	·	·	✓
SRO	Heart rate increased	✓	·	✓
SRO	Paraesthesia	✓	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release